Avidity Partners Management LP Ventyx Biosciences, Inc. Transaction History

Avidity Partners Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$29.8 - $40.3 $10.1 Million - $13.6 Million	-337,600 Reduced 48.75%	354,900 $12.3 Million
Q2 2023 Aug 14, 2023	SELL	$28.53 - $39.55 $35 Million - $48.5 Million	-1,225,300 Reduced 63.89%	692,500 $22.7 Million
Q1 2023 May 15, 2023	BUY	$29.51 - $46.65 $18.7 Million - $29.5 Million	632,800 Added 49.25%	1,917,800 $64.2 Million
Q4 2022 Feb 14, 2023	BUY	$24.16 - $36.38 $31 Million - $46.7 Million	1,285,000 New	1,285,000 $42.1 Million

125

52.9M

35.3K

83K

Ticker VTYX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,527,200
Market Cap $135M
Description
Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

Stay updated on Avidity Partners Management LP with notifications on news.